RecruitingPhase 1NCT07613723
Oncology
Synovial sarcoma
25
studies recruiting now
as of 7 Sept 2026
152
studies registered in total
as of 7 Sept 2026
6
countries with a recruiting site
as of 7 Sept 2026
29 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT05711615
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1NCT06644755
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
RecruitingEarly phase 1NCT07261657
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
RecruitingPhase 1 / Phase 2NCT05642455
SPEARHEAD-3 Pediatric Study
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 25 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Synovial sarcoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Synovial sarcoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (SS18, SSX1, SSX2).
Treatments being studied
1 approved treatment and 12 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Afamitresgene Autoleucel (Tecelra)
Phase 3Catequentinib
Phase 3Dacarbazine (Dacarbazine)
Phase 2Adenosine Diphosphate
Phase 2Letetresgene Autoleucel
Phase 2Ipilimumab (Yervoy)
Phase 2Imatinib Mesylate (Gleevec)
Phase 1/2Docetaxel (Beizray)
Phase 1/2Ramucirumab (Cyramza)
+ 4 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).